Attenuation of glial scar formation in the injured rat brain by heparin oligosaccharides

Neuroscience Research

Volumn 49, Issue 1, 2004, Pages 19-27

  Hayashi, Noriko ^a   Miyata, Seiji ^a   Kariya, Yutaka ^b   Takano, Ryo ^a   Hara, Saburo ^a   Kamei, Kaeko ^a  

^a KYOTO INSTITUTE OF TECHNOLOGY   (Japan)

^b SEIKAGAKU CORPORATION   (Japan)

Author keywords

Central nervous system; Gliosis; Heparin; Injury; Scar inhibition; Scarring

Indexed keywords

ANTIBODY; CHONDROITIN 4 SULFATE; GLIAL FIBRILLARY ACIDIC PROTEIN; HEPARIN; OLIGOSACCHARIDE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; ASTROCYTE; BRAIN CORTEX; BRAIN INJURY; CONTROLLED STUDY; IMMUNOREACTIVITY; INJECTION SITE; MALE; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCAR FORMATION;

ANIMALS; ASTROCYTES; BRAIN INJURIES; CELL COUNT; GLIAL FIBRILLARY ACIDIC PROTEIN; GLYCOPROTEINS; HEPARIN; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, CONFOCAL; OLIGOSACCHARIDES; RATS; RATS, WISTAR; WOUND HEALING;

EID: 16544392410     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2004.01.007     Document Type: Article

References (53)

1. Asada S., Kasuya Y., Hama H., Masaki T., Goto K. Cytodifferentiation potentiates aFGF-induced p21 (ras)/Erk signaling pathway in rat cultured astrocytes. Biochem. Biophys. Res. Commun. 260:1999;441-445.
2. Asher R.A., Morgenstern D.A., Fidler P.S., Adcock K.H., Oohira A., Braistead J.E., Levine J.M., Margolis R.U., Rogers J.H., Fawcett J.W. Neurocan is upregulated in injured brain and in cytokine-treated astrocytes. J. Neurosci. 20:2000;2427-2438.
3. Asher R.A., Morgenstern D.A., Shearer M.C., Adcock K.H., Pesheva P., Fawcett J.W. Versican is upregulated in CNS injury and is a product of oligodendrocyte lineage cells. J. Neurosci. 22:2002;2225-2236.
4. Bradbury E.J., Moon L.D., Popat R.J., King V.R., Bennett G.S., Patel P.N., Fawcett J.W., McMahon S.B. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature. 416:2002;636-640.
5. Clarke W.E., Berry M., Smith C., Kent A., Logan A. Coordination of fibroblast growth factor receptor 1 (FGFR1) and fibroblast growth factor-2 (FGF-2) trafficking to nuclei of reactive astrocytes around cerebral lesions in adult rats. Mol. Cell. Neurosci. 17:2001;17-39.
6. Clement A.M., Nadanaka S., Masayama K., Mandle C., Sugahara K., Faissner A. The DSD-1 carbohydrate epitope depends on sulfation, correlates with chondroitin sulfate D motifs, and is sufficient to promote neurite outgrowth. J. Biol. Chem. 273:1998;28444-28453.
7. Coumans J.V., Lin T.T., Dai H.N., MacArthur L., McAtee M., Nash C., Bregman B.S. Axonal regeneration and functional recovery after complete spinal cord transection in rats by delayed treatment with transplants and neurotrophins. J. Neurosci. 21:2001;9334-9344.
8. Eclancher F., Kehrli P., Labourdette G., Sensenbrenner M. Basic fibroblast growth factor (bFGF) injection activates the glial reaction in the injured adult rat brain. Brain Res. 737:1996;201-214.
9. Faber-Elman A., Solomon A., Abraham J.A., Marikovsky M., Schwartz M. Involvement of wound-associated factors in rat brain astrocyte migratory response to axonal injury: in vitro simulation. J. Clin. Invest. 97:1996;162-171.
10. Fawcett J.W., Asher R.A. The glial scar and central nervous system repair. Brain Res. Bull. 49:1999;377-391.
11. Goddard D.R., Berry M., Kirvell S.L., Butt A.M. Fibroblast growth factor-2 induces astroglial and microglial reactivity in vivo. J. Anat. 200:2002;57-67.
12. Gómez-Pinilla F., Vu L., Cotman C.W. Regulation of astrocyte proliferation by FGF-2 and heparan sulfate in vivo. J. Neurosci. 15:1995;2021-2029.
13. Gómez-Pinilla F., Miller S., Choi J., Cotman C.W. Heparan sulfate potentiates the autocrine action of basic fibroblast growth factor in astrocyte: an in vivo and in vitro study. Neuroscience. 76:1997;137-145.
14. Hajihosseini M.K., Dickson C. A subset of fibroblast growth factors (Fgfs) promote survival but Fgf-8b specifically promotes astroglial differentiation of rat cortical precursor cells. Mol. Cell. Neurosci. 14:1999;468-485.
15. Jayson G.C., Gallagher J.T. Heparin oligosaccharides: inhibitors of the biological activity of bFGF on Caco-2 cell. Br. J. Cancer. 75:1997;9-16.
16. Joy A., Moffett J., Neary K., Mordechai E., Stachowiak E.K., Coons S., Rankin-Shapiro J., Florkiewicz R.Z., Stachowiak M.K. Nuclear accumulation of FGF-2 is associated with proliferation of human astrocytes and glioma cells. Oncogene. 14:1997;171-183.
17. Kernie S.G., Erwin T.M., Parada L.F. Brain remodeling due to neuronal and astrocytic proliferation after controlled cortical injury in mice. J. Neuorsci. 66:2001;317-326.
18. Knuckey N.W., Finch P., Palm D.E., Primiano M.J., Johanson C.E., Flanders K.C., Thompson N.L. Differential neuronal and astrocytic expression of transforming growth factor β isoforms in rat hippocampus following transient forebrain ischemia. Brain Res. Mol. Brain Res. 40:1996;1-14.
19. Lagord C., Berry M., Logan A. Expression of TGFβ2 but not TGFβ1 correlates with the deposition of scar tissue in the lesioned spinal cord. Mol. Cell. Neurosci. 20:2002;69-92.
20. Lee C.Y., Pappas G.D., Kriho V., Huang B.M., Yang H.Y. Proliferation of a subpopulation of reactive astrocytes following needle-insertion lesion in rat. Neurol. Res. 25:2003;767-776.
21. Levine J.M. Increased expression of the NG2 chondroitin-sulfate proteoglycan after brain injury. J. Neurosci. 14:1994;4716-4730.
22. Logan A., Berry M., Gonzalez A.M., Frautschy S.A., Sporn M.B., Baird A. Effects of transforming growth factor beta1 on scar production in the injured central nervous system of the rat. Eur. J. Neurosci. 6:1994;355-363.
23. Logan A., Frautschy S.A., Gonzales A.M., Baird A. A time course for the focal elevation of synthesis of basic fibroblast growth factor and one of its high-affinity receptors (flg) following a localized cortical brain injury. J. Neurosci. 12:1992;3828-3837.
24. Logan A., Green J., Hunter A., Jackson R., Berry M. Inhibition of glial scarring in the injured rat brain by a recombinant human monoclonal antibody to transforming growth factor-β2. Eur. J. Neurosci. 11:1999a;2367-2374.
25. Logan A., Baird A., Berry M. Decorin attenuates gliotic scar formation in the rat cerebral hemisphere. Exp. Neurol. 159:1999b;504-510.
26. Loo B.M., Salmivirta M. Heparin/heparan sulfate domains in binding and signaling of fibroblast growth factor 8b. J. Biol. Chem. 277:2002;32616-32623.
27. Lyon M., Rushton G., Gallagher J.T. The interaction of the transforming growth factor-betas with heparin/heparan sulfate is isoforms-specific. J. Biol. Chem. 272:1997;18000-18006.
28. Maeda N., He J., Yajima Y., Mikami T., Sugahara K., Yabe T. Heterogeneity of the chondroitin sulfate portion of phosphacan/6B4 proteoglycan regulates its binding affinity for pleiotrophin/heparin binding growth-associated molecule. J. Biol. Chem. 278:2003;35805-35811.
29. Matsui F., Kawashima S., Shuo T., Yamauchi S., Tokita Y., Aono S., Keino H., Oohira A. Transient expression of juvenile-type neurocan by reactive astrocytes in adult rat brains injured by kainate-induced seizures as well as surgical incision. Neuroscience. 112:2000;773-781.
30. Mervis, R., McKean, J., Zats, S., Gum, A., Reinhard, R., Dudas, B., Cornelli, U., Lee, J.M., Lorens, S.A., Fareed, J., Hanin, I., 2000. Neurotrophic effects of the glycosaminoglycan C3 on dendritic arborization and spine in the adult rat hippocampus: quantitative Golgi study. CNS Drug Rev. 6, 44-46.
31. Miyata S., Matsumoto N., Taguchi K., Akagi A., Iino T., Funatsu N., Maekawa S. Biochemical and ultrastructural analyses of IgLON cell adhesion molecules. Kilon and OBCAM in the rat brain. Neuroscience. 117:2003a;645-658.
32. Miyata S., Taguchi K., Maekawa S. Dendrite-associated opioid-binding cell adhesion molecule localizes at neurosecretory granules in the hypothalamic magnocellular neurons. Neuroscience. 122:2003b;169-181.
33. Moon L.D., Fawcett J.W. Reduction in CNS scar formation without concomitant increase in axon regeneration following treatment of adult rat brain with a combination of antibodies to TGF β1 and β2. Eur. J. Neurosci. 14:2001;1667-1677.
34. Moon L.D., Asher R.A., Rhodes K.E., Fawcett J.W. Regeneration of CNS axons back to their target following treatment of adult rat brain with chondroitinase ABC. Nat. Neurosci. 4:2001;465-466.
35. Morgan T.E., Nichols N.R., Pasinetti G.M., Finch C.E. TGF-β1 mRNA increases in macrophage/microglial cells of hippocampus in response to deafferentation and kainic acid-induced neurodegeneration. Exp. Neurol. 120:1993;291-301.
36. Nadanaka S., Clement A., Masayama K., Faissner A., Sugahara K. Characteristic hexasaccharide sequences in octasaccharides derived from shark cartilage chondroitin sulfate D with a neurite outgrowth promoting activity. J. Biol. Chem. 273:1998;3296-3307.
37. Planas A.M., Justicia C., Soriano M.A., Ferrer I. Epidermal growth factor receptor in proliferating reactive glia following transient focal ishemia in the rat brain. Glia. 23:1998;120-129.
38. Rabchevsky A.G., Weinitz J.M., Coulpier M., Fages C., Tinel M., Junier M.P. A role for transforming growth factor alpha as an inducer of astrogliosis. J. Neurosci. 18:1998;10541-10552.
39. Reilly J.F., Bair L., Kumari V.G. Heparan sulfate modifies the effects of basic fibroblast growth factor on glial reactivity. Brain Res. 759:1997;277-284.
40. Reilly J.F., Maher P.A., Kumari V.G. Regulation of astrocyte GFAP expression by TGF-beta1 and FGF-2. Glia. 22:1998;202-210.
41. Reilly J.F., Kumari V.G. Alterations in fibroblast growth factor receptor expression following brain injury. Exp. Neurol. 140:1996;139-150.
42. Riboni L., Viani P., Bassi V., Stabilini A., Tettamanti G. Biomodulatory role of ceramide in basic fibroblast growth factor-induced proliferation of cerebellar astrocytes in primary culture. Glia. 32:2000;137-145.
43. Riboni L., Viani P., Bassi V., Giussani P., Tettamanti G. Basic fibroblast growth factor-induced proliferation of primary astrocytes. J. Biol. Chem. 276:2001;12797-12804.
44. Ridet J.L., Malhotra S.K., Privat A., Gage F.H. Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci. 20:1997;570-577.
45. Rose M., Dudas B., Cornelli U., Lee J.M., Lorens S.A., Mervis R.F., Fareed J., Hanin I. Protective effect of glycosaminoglycan C3 on AF64A-induced cholinergic lesions in rats. Neurobiol. Aging. 24:2003;481-490.
46. Simpson D.L., Morrison R., de Vellis J., Herschman H.R. Epidermal growth factor binding and mitogenic activity on purified populations of cells from the central nervous system. J. Neurosci. 8:1982;453-462.
47. Stauber D.J., DiGabriele A.D., Hendrickson W.A. Structural interactions of fibroblast growth factor receptor with its ligands. Proc. Natl. Acad. Sci. U.S.A. 97:2000;49-54.
48. Tabeur C., Mallet J.M., Bono F., Herbert J.M., Petitou M., Sinay P. Oligosaccharides corresponding to the regular sequence of heparin: chemical synthesis and interaction with FGF-2. Bioorg. Med. Chem. 7:1999;2003-2012.
49. Thon N., Haas C.A., Rauch U., Merten T., Fässler R., Frotscher M., Deller T. The chondroitin sulphate proteoglycan brevican is upregulated by astrocytes after entorhinal cortex lesions in adult rats. Eur. J. Neurosci. 12:2000;2547-2558.
50. Tokita Y., Keino H., Matusi F., Aono S., Ishiguro H., Higashiyama S., Oohira A. Regulation of neuregulin expression in the injured rat brain and cultured astrocytes. J. Neuorsci. 21:2001;1257-1264.
51. Weigert C., Brodbeck K., Haring H.U., Gambaro G., Schleicher E.D. Low-molecular-weight heparin prevents high glucose- and phorbol ester-induced TGFβ1 gene activation. Kidney Int. 60:2001;935-943.
52. Wickelgren I. Neuroscience. Animal studies raise hopes for spinal cord repair. Science. 297:2002;178-181.
53. Xu X., Takano R., Nagai Y., Yanagida T., Kamei K., Kato H., Kamikubo Y., Nakahara Y., Kumeda K., Hara S. Effect of heparin chain length on the interaction with tissue factor pathway inhibitor (TFPI). Int. J. Biol. Macromol. 30:2002;151-160.